Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 May 12;2:1. doi: 10.1186/s40661-015-0008-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Cobb et al. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

The dualistic pathways in developing low-grade and high-grade “ovarian” serous carcinoma. The Type I pathway develops from the presumed fallopian tube epithelial stem cells that disseminated into the ovulation site where those stem cells form surface inclusion cysts. Those cysts may continue to grow into serous cystadenomas and clonally develop into serous borderline tumors, which represent the precursor lesions of low-grade serous carcinomas. In contrast to the step-wise tumor progression pathway as observed in Type I serous tumors, in the Type 2 pathway, many high-grade serous carcinomas arise as a result of dissemination of their precursor lesions, serous tubal intraepithelial carcinomas (STICs), in the fallopian tube fimbriated ends.